Dermatological Drug Market - Forecasts from 2019 to 2024
The global dermatological drug market is projected to grow at a CAGR of 5.50% to reach US$42.399 billion by 2024, from US$30.742 billion in 2018. The demand for dermatological drugs is rising due to growing skin diseases, rising disposable and out-of-pocket incomes and growing awareness regarding skin health. Common medications for skin indications include antibacterial, anthralin, antifungals, retinoids etc.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global dermatological drug value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global dermatological drug market.
Major industry players profiled as part of the report are AbbVie Inc., Curatio Healthcare, Sienna Biopharmaceuticals, Glenmark and NovaBay Pharmaceuticals, Inc. among others.
Segmentation
The global dermatological drug market has been analyzed through following segments:
By Indication
Psoriasis
Acne
Dermatitis
Others
By Route of Administration
Topical
Oral
Parenteral
By End User
Hospitals and Clinics
Cosmetic Centers
Others
By Geography
North America
USA
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Others
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global dermatological drug value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global dermatological drug market.
Major industry players profiled as part of the report are AbbVie Inc., Curatio Healthcare, Sienna Biopharmaceuticals, Glenmark and NovaBay Pharmaceuticals, Inc. among others.
Segmentation
The global dermatological drug market has been analyzed through following segments:
By Indication
Psoriasis
Acne
Dermatitis
Others
By Route of Administration
Topical
Oral
Parenteral
By End User
Hospitals and Clinics
Cosmetic Centers
Others
By Geography
North America
USA
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL DERMATOLOGICAL DRUG MARKET BY INDICATION
5.1. Psoriasis
5.2. Acne
5.3. Dermatitis
5.4. Others
6. BY ROUTE OF ADMINISTRATION
6.1. Topical
6.2. Oral
6.3. Parenteral
7. BY END USER
7.1. Hospitals and Clinics
7.2. Cosmetic Centers
7.3. Others
8 GLOBAL DERMATOLOGICAL DRUG MARKET BY GEOGRAPHY
8.1 North America
8.1.1 USA
8.1.2 Canada
8.1.3 Mexico
8.1.4 Others
8.1. South America
8.2.1 Brazil
8.2.2 Argentia
8.2.3 Others
8.2. Europe
8.3.1 Germany
8.3.2 France
8.3.3 United Kingdom
8.3.4 Spain
8.3.5 Others
8.3. Middle East and Africa
8.3.1. Saudi Arabia
8.3.2. Israel
8.3.3. Others
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. South Korea
8.4.4. India
8.4.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competition and Offerings Analysis of Key Vendors
9.2. Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. AbbVie Inc.
10.2. Curatio Healthcare
10.3. Sienna Biopharmaceuticals
10.4. Glenmark
10.5. NovaBay Pharmaceuticals, Inc.
10.6. THESAN PHARMACEUTICAL INC.
10.7. Vyome Biosciences
10.8. Aclaris Therapeutics, Inc.
10.9. Bausch Health Companies Inc.
10.10. Galderma
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL DERMATOLOGICAL DRUG MARKET BY INDICATION
5.1. Psoriasis
5.2. Acne
5.3. Dermatitis
5.4. Others
6. BY ROUTE OF ADMINISTRATION
6.1. Topical
6.2. Oral
6.3. Parenteral
7. BY END USER
7.1. Hospitals and Clinics
7.2. Cosmetic Centers
7.3. Others
8 GLOBAL DERMATOLOGICAL DRUG MARKET BY GEOGRAPHY
8.1 North America
8.1.1 USA
8.1.2 Canada
8.1.3 Mexico
8.1.4 Others
8.1. South America
8.2.1 Brazil
8.2.2 Argentia
8.2.3 Others
8.2. Europe
8.3.1 Germany
8.3.2 France
8.3.3 United Kingdom
8.3.4 Spain
8.3.5 Others
8.3. Middle East and Africa
8.3.1. Saudi Arabia
8.3.2. Israel
8.3.3. Others
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. South Korea
8.4.4. India
8.4.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competition and Offerings Analysis of Key Vendors
9.2. Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. AbbVie Inc.
10.2. Curatio Healthcare
10.3. Sienna Biopharmaceuticals
10.4. Glenmark
10.5. NovaBay Pharmaceuticals, Inc.
10.6. THESAN PHARMACEUTICAL INC.
10.7. Vyome Biosciences
10.8. Aclaris Therapeutics, Inc.
10.9. Bausch Health Companies Inc.
10.10. Galderma
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER
